ADA Scientific Sessions 2025 Abstract
The High Prevalence of Metabolic Dysfunction–Associated Steatohepatitis (MASH) in People with T2D Support the Need for Screening to Prevent Future Cirrhosis
Study in peoplePopulations
Papers by Stephen A. Marangi
1 result